Jeffrey M. Leiden is a businessperson who founded CardioGene Therapeutics, Inc. and who has been the head of 9 different companies. Currently, Dr. Leiden holds the position of Executive Chairman of Vertex Pharmaceuticals, Inc., Non-Executive Chairman at Tmunity Therapeutics, Inc. and Chairman for PathAI, Inc. Jeffrey M. Leiden is also Member of American Academy of Arts & Sciences, Member of Institute of Medicine, Member of Association of American Physicians, Member of American Society of Clinical Investigation and Member of National Academy of Medicine of United States and on the board of 6 other companies.
In his past career he held the position of Chairman at Lycera Corp., President & Chief Operating Officer of Abbott Laboratories, Chairman at TYRX, Inc., Chairman at Variation Biotechnologies (US), Inc., Managing Director at Clarus Ventures LLC, President & Chief Operating Officer for Pharmaceutical Products, Member of National Heart, Lung & Blood Institute, Chief Cardiology Officer at The University of Chicago, Professor at Harvard Medical School and Professor-Biological Sciences at Harvard T.H. Chan School of Public Health.
Dr. Leiden received a doctorate and an undergraduate degree from The University of Chicago.